Friday, August 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Maintains Bullish Stance on Petco Health and Wellness Lowers Price Target

Elaine Mendonca by Elaine Mendonca
March 15, 2024
in Breaking News
0
Retail Stock Bull Market
0
SHARES
16
VIEWS
Share on FacebookShare on Twitter

On March 15, 2024, RBC Capital analyst Steven Shemesh reiterated his bullish stance on Petco Health and Wellness (NASDAQ: WOOF), maintaining an Outperform rating. However, he revised the price target from $3.5 to $2.7, indicating his confidence in the company’s potential despite the lower target. Shemesh’s optimism underscores his belief in Petco’s ability to thrive in the market.

WOOF Stock Shows Positive Momentum with 3.64% Increase on March 15, 2024: Is it a Buying Opportunity?

On March 15, 2024, WOOF stock showed some positive momentum with a 3.64% increase in its share price. The stock opened at $2.06, which was in line with its previous close. Despite this, WOOF is still trading near the bottom of its 52-week range and below its 200-day simple moving average.

The increase of $0.07 in the share price may indicate some bullish sentiment among investors. However, it is important to note that the stock is still trading at a relatively low price compared to its historical performance. This could be a potential buying opportunity for investors who believe in the long-term growth prospects of WOOF.

WOOF Stock Performance Analysis: Revenue Flat, Net Income Decreases, EPS Improves in Q4 2024

On March 15, 2024, WOOF stock performance was closely scrutinized by investors and analysts after the company released its financial data for the past year and the fourth quarter.

According to the data, WOOF reported a total revenue of $6.25 billion for the past year, which represented a 3.63% increase compared to the previous year. However, the total revenue remained flat since the last quarter, standing at $1.67 billion.

In terms of net income, WOOF reported a significant decrease in profitability over the past year. The company recorded a net income of -$1.28 billion, marking a 1509.91% decrease compared to the previous year. However, there was a slight improvement in net income for the fourth quarter, with a reported loss of -$22.57 million, which represented a 98.18% increase compared to the previous quarter.

Earnings per share (EPS) also showed a similar trend to net income. WOOF reported an EPS of -$4.79 for the past year, indicating a 1501.58% decrease compared to the previous year. However, there was a notable improvement in EPS for the fourth quarter, with a reported loss of -$0.08, representing a 98.19% increase compared to the previous quarter.

Overall, WOOF’s stock performance on March 15, 2024, reflected a mixed bag of results. While the company showed some signs of improvement in net income and EPS for the fourth quarter, the flat revenue growth and significant decrease in profitability over the past year may have raised concerns among investors. It will be interesting to see how WOOF navigates these challenges in the coming months and whether the company can sustain its growth trajectory in the long run.

Tags: WOOF
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Brake switch Walmart

Market Sentiment and Options Activity for ArcherDaniels Midland ADM

does costco do random drug test

Boeings Future Prospects Upgraded to Stable Outlook by Fitch Ratings

Finance_Financing

Title Truist Securities Analyst Upgrades Price Target for Karat Packaging Inc to 33

Recommended

Palantir Stock

Palantir Shares Face Valuation Pressures Despite Strong Earnings

9 months ago
BridgeBio Pharma Stock

BridgeBio Pharma Investors Await Critical Heart Drug Data

9 months ago
Ocugen Stock

Ocugen’s Fresh $130M Cushion Sets the Stage for a Data-Heavy July and a Pivotal Regulatory Filing

1 month ago
Airbnb Stock

Navigating Regulatory Headwinds and Innovation: Airbnb’s Strategic Crossroads

10 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

MSCI World ETF: Index Provider Rewrites the Rulebook for Fast-Moving Stocks

Airbus’ Paradox: A Slightly Smaller Forecast That Nobody Seems to Mind

Almonty Industries Rebounds From Index-Driven Exit as Tungsten Calculus Shifts Westward

OHB’s Two-Faced Half-Year: Record Orders Mask a Profit Squeeze That Spooked the Market

Trending

Nel ASA Stock
Analysis

Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding

by Jackson Burston
August 7, 2026
0

The Norwegian electrolyser maker Nel ASA is living a split-screen reality. Its order intake just exploded by...

SANDISK Stock

SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market

August 7, 2026
Bitcoin Stock

Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

August 7, 2026
Kioxia Stock

Kioxia’s Unsettling Arithmetic: Record Profits, a $229 Million Verdict, and a Stock Still Searching for Its Floor

August 7, 2026
FALLBACK Stock

French Top Court Settles Disputes Over Expert Fees, Strike Notices and the AGS Wage Guarantee

August 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Nel ASA’s Two-Speed Story: Orders Accelerate While the P&L Keeps Bleeding
  • SanDisk’s $94 Billion Backlog Can’t Bridge the Gap Between Record Results and a Disappointed Market
  • Payrolls Shrink, Rate-Cut Bets Return, and Crypto’s Plumbing Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com